2nd Annual Gene Therapy Analytical Development EU
In the context of unprecedented gene therapy investment and clinical progress, with mounting regulatory scrutiny, Gene Therapy Analytical Development Europe will unite innovative biotech and pharma organisations to develop robust analytical tools to guarantee the consistency, quality, and safety of gene therapy products.
On Day 1 (May 26) at 8.00 am BST, our Head of Upstream Process Development, Ivana Petrović Koshmak, PhD, will talk about In-Process Analytics of AAV vector capsid production.